Xcelthera is a biopharmaceutical company developing a stem cell therapy for neurological and cardiovascular diseases. It provides a range of products, including clinical-grade human heart precursor cells (Xcel-hCardP) and heart muscle cells (Xcel-hCM) for contractile heart muscle regeneration or replacement therapies as well as clinical-grade human neuronal progenitor cells (Xcel-hNuP) and neurons (Xcel-hNu) for neuron regeneration therapies.